HOME >> BIOLOGY >> NEWS
Turning down the Sun

reduction in fossil fuels might entail.

"Teller and Wood are technical optimists, and pessimists about human behaviour," says Caldeira, who saw Wood present their work in 1998, and was disturbed by the re-emergence of these Sun-blocking proposals. "My hope was to show that it wouldn't work," he says, "so people would give up on it."

Caldeira thought he saw a central flaw in all of these Sun-dimming ideas. While reducing sunlight might have an overall cooling effect on the planet as a whole, he argued, it wouldn't counteract the local heating effect from CO2. The two forces act in a completely different way on different parts of the globe. The capacity of CO2 to trap heat increases with temperature, so it's more effective near the equator. The Sun, on the other hand, shines more in the northern hemisphere in June, more in the southern hemisphere in December. Surely, thought Caldeira, these very different phenomena couldn't exactly cancel each other out? Not on a country-sized scale, or over the different seasons. Instead, he expected the winters to get warmer and the summers cooler, the poles warmer and the tropics cooler. In short, many of the problems the Earth faces from global warming-the seasons becoming more and more alike, and a variety of weird weather (New Scientist, 16 September, p 26)-would be made worse.

To try to prove his hypothesis, Caldeira went to work with his colleague Bala Govindasamy and a hefty climate-modelling program. They invented three future worlds to test. In the first, the control model, levels of atmospheric CO2 were set at just 280 parts per million-the pre-industrial value-and the Sun shone at a constant 1367 watts per square metre at the Earth's surface. In the second, there was twice as much CO2, adding an extra 4.17 watts per square metre to the Earth-bound radiation. In the final, geoengineered scenario, the doubled CO2 was countered by cutting 1.8 per cent of the Sun's light, again worth 4.17 watts per square metre.
'"/>

Contact: Claire Bowles
claire.bowles@rbi.co.uk
44-207-331-2751
New Scientist
19-Sep-2000


Page: 1 2 3 4 5 6 7 8

Related biology news :

1. Turning bone into nerve
2. Turning foe into friend with lentiviral vectors
3. Turning off building lights reduces bird window-kill by 83%
4. Turning blood into brain: new studies suggest bone marrow stem cells can develop into neurons in living animals
5. Turning salt and water into wine
6. UNC Researchers Reduce Arthritis Severity By Turning Off Molecular Switch
7. Turning "Unrecyclable" Waste Into Plastic Products
8. Survey Shows Students Turning To Physicians Less As Drug Abuse Increases
9. Africa At The Turning Point
10. Nitric Oxide Found To Control Cells By Turning On Genes; Suggests New Role In Health And Disease

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Turning down the Sun

(Date:12/19/2014)... 18, 2014   LaunchKey , the first decentralized mobile ... Internet of Things era, today announced the close of ... was led by Metamorphic Ventures with participation from ENIAC ... and others.  LaunchKey has raised $4 million to date, ...
(Date:12/17/2014)... Valencell, a leader in performance biometric data sensor ... leaders such as Intel, Jabra, Atlas, and Scosche to ... These products will be showcased at CES 2015, taking ... . "Our partners choose PerformTek biometrics, ...
(Date:12/11/2014)... and Markets , http://photos.prnewswire.com/prnh/20130307/600769 ... the addition of the "Biometrics Market in the ... One major trend emerging in this market is ... is important to upgrade biometric solutions to the latest ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
(Date:12/24/2014)... Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market approval application ... the use of Medtronic,s SynchroMed ® II implantable ... use with United Therapeutics, Remodulin ® (treprostinil) Injection ...
(Date:12/24/2014)...  Vermillion, Inc. (Nasdaq:   VRML), a bio-analytical solutions ... the Company closed its previously announced private placement ... W. Schuler , Birchview Fund LLC and several ... offering expenses.  The proceeds will be used for ...
(Date:12/24/2014)... (PRWEB) December 23, 2014 “Preparative ... Gas, HPLC, Flash), Consumables (Columns, Solvents, Buffers, Valves, ... Food & Agriculture) - Forecasts to 2019” provides ... challenges, opportunities, current market trends, and strategies impacting ...
(Date:12/24/2014)... Earlier this year in a June 24 international conference presentation, ... Technology Center, LLC ( ASCTC ) focused attention on an ... stem cells. His title “Asymmetric Self-Renewal by Distributed Stem ... the essence of his message to congress participants. He ...
Breaking Biology Technology:United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4
Cached News: